Dr. Nicholas Oberlies (Chemistry & Biochemistry) received new funding from the National Institutes of Health – National Institute of Allergy and Infectious Diseases for the project “Anti-Malarial Drug Leads from Fungi.”
This project targets the discovery of anti-malarial drug leads from a library of fungal cultures.